Top Markets
Coin of the day
Avisa Diagnostics Inc. Avisa Diagnostics Inc.

Avisa Diagnostics Inc.

AVBT
Rank in Stocks #40597
Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa... Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa Fe, New Mexico, is dedicated to developing the Avisa BreathTest. This innovative drug/device biomarker technology platform is designed for the ultra-rapid identification of virulent bacterial pathogens and the subsequent monitoring of bacterial load. The system works by analyzing a patient's breath after they have inhaled or ingested Avisa's proprietary drug substrates. The company has already established clinical proof-of-concept through trials in conditions such as cystic fibrosis, tuberculosis, and community-acquired pneumonia, and is now concentrating on pivotal trials for Post-COVID-19 bronchiectasis and ventilator-associated pneumonia.
Share Price
$0.0333321
Last synced: 2023-05-23
Market Cap
$114.40K
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
US
Trade Avisa Diagnostics Inc. (AVBT)

Category

P/B ratio for Avisa Diagnostics Inc. (AVBT)
P/B ratio as of 2026 TTM: 0
According to Avisa Diagnostics Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Avisa Diagnostics Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
3.6048 -
US
5.207 -
US
2.0146 -
IE
2.6697 -
US
4.8038 -
US